Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.74 is 96% above its 5-year average of 1.90, around the middle of its 5-year range (0.00–5.61).
As of the fiscal period ended Tuesday, June 30, 2026. 77.41% above its 12-month average of 2.11.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.74.
CURRENT RATIO
3.74
CURRENT RATIO AVG TTM
2.11
CURRENT RATIO AVG 3Y
0.94
CURRENT RATIO AVG 5Y
1.90
CURRENT RATIO AVG 10Y
2.70
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+77.41%
CURRENT VS 3Y AVG
+297.02%
CURRENT VS 5Y AVG
+96.36%
CURRENT VS 10Y AVG
+38.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
+5.38%
vs the sector median at left
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.13M
Current Ratio
3.74
TTM Avg
2.11
3Y Avg
0.94
5Y Avg
1.90
Market Cap
$51.28M
Current Ratio
5.31
TTM Avg
2.85
3Y Avg
8.26
5Y Avg
15.41
Market Cap
$52.65M
Current Ratio
12.87
TTM Avg
3.88
3Y Avg
3.88
5Y Avg
3.88
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.13M | 3.74 | 2.11 | 0.94 | 1.90 |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | 1.73 | 0.89 | 0.86 | 0.91 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.28M | 5.31 | 2.85 | 8.26 | 15.41 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 3.81 | 5.31 | 3.36 | 3.21 |
| INmune Bio, Inc. (INMB)vs › | $50.64M | 4.04 | 3.34 | 3.69 | 7.87 |
| Clene Inc. (CLNN)vs › | $51.05M | 3.07 | 1.20 | 1.51 | 3.42 |
| Celularity Inc. (CELU)vs › | $50.58M | 0.09 | 0.27 | 0.34 | 1.05 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.65M | 12.87 | 3.88 | 3.88 | 3.88 |
| Microbot Medical Inc. (MBOT)vs › | $50.20M | 18.56 | 12.85 | 8.01 | 9.80 |
| Apollomics, Inc. (APLM)vs › | $49.85M | 0.96 | 1.17 | 2.45 | 5.02 |
Current Ratio
3.74
Quick Ratio
3.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.74 |
| 2026-03-31 | 0.48 |
| 2025-03-31 | 0.00 |
| 2023-09-30 | 0.24 |
| 2023-06-30 | 0.25 |
| 2023-03-31 | 0.33 |
| 2022-12-31 | 0.87 |
| 2022-09-30 | 1.18 |
| 2022-06-30 | 1.62 |
| 2022-03-31 | 2.20 |
| 2021-12-31 | 4.37 |
| 2021-09-30 | 5.61 |
| 2021-06-30 | 3.85 |
| 2021-03-31 | 1.57 |
| 2020-12-31 | 2.63 |
| 2020-09-30 | 3.23 |
| 2020-06-30 | 3.62 |
| 2020-03-31 | 4.14 |
| 2019-12-31 | 4.89 |
| 2019-09-30 | 5.95 |
| 2019-06-30 | 7.07 |
| 2019-03-31 | 6.58 |
| 2018-12-31 | 6.45 |
| 2018-09-30 | 11.05 |
| 2018-06-30 | 14.69 |
| 2018-03-31 | 3.33 |
| 2017-06-30 | 0.10 |
| 2017-03-31 | 0.26 |
| 2016-12-31 | 0.26 |
| 2016-09-30 | 0.80 |
| 2016-06-30 | 2.66 |
| 2016-03-31 | 4.25 |
| 2015-12-31 | 4.72 |
| 2015-09-30 | 5.41 |
